Lefluartil

Leflunomide, the active ingredient in Lefluartil, is an immunomodulatory agent presented as an oral formulation for oral use. It is employed to manage chronic inflammatory joint diseases, primarily in adult patients with rheumatoid arthritis or psoriatic arthritis.

GNH USA supplies Lefluartil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory support across EU and other markets.

Leflunomide is a disease-modifying antirheumatic drug that modulates immune activity in inflammatory arthritis. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage in adult patients. - Psoriatic arthritis: alleviates skin and joint symptoms and improves functional capacity. - Inadequately controlled inflammatory arthritis: provides an alternative when response to first‑line DMARDs is insufficient.

Leflunomide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may affect hydration. - Elevated liver enzymes: mild transaminase increases. - Rash: skin irritation or mild eruption.

Serious or Rare Side Effects: - Severe liver injury: hepatitis or hepatic failure. - Bone marrow suppression: anemia, leukopenia, or thrombocytopenia. - Stevens‑Johnson syndrome: severe skin and mucosal reaction.

When prescribing Leflunomide, clinicians should observe several precautionary measures to minimize risk. - Monitor liver function: obtain baseline transaminases and repeat regularly. - Check blood pressure: control hypertension before and during therapy. - Perform complete blood count: watch for anemia, leukopenia, or thrombocytopenia. - Avoid use in severe hepatic impairment: contraindicated in patients with existing liver disease. - Contraindicated in pregnancy: ensure effective contraception and discontinue if pregnancy occurs. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Leflunomide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, risk of bleeding. - Teriflunomide (active metabolite of leflunomide): additive toxicity, avoid concurrent use. - Carbamazepine: induces metabolism, reducing leflunomide plasma levels.

Moderate Interactions (Monitor Closely): - Statins: may increase risk of muscle toxicity. - Oral contraceptives: reduced hormonal efficacy, advise additional contraceptive methods.